Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.
Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents.
Vahid
Bobbak
B
Dominican Hospital, Santa Cruz Pulmonary Medical Group, Santa Cruz, CA, USA. bobbak_vahid@yahoo.com
Marik
Paul E
PE
D000970:Antineoplastic Agents / Q000009:adverse effects*; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000628:therapy
D000970:Antineoplastic Agents